Mochida, JP3922800002

Mochida Pharmaceutical stock reports higher quarterly profit ahead of October 30

Published on 10/07/2026 at 02:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mochida Pharmaceutical stock traded at JPY 3,120 on October 7, 2026, while fiscal Q1 revenue reached JPY 31.719 billion. Net income rose to JPY 3.178 billion from JPY 1.561 billion.

Mochida, JP3922800002, Illustration mit AI erstellt.
Mochida, JP3922800002, Illustration mit AI erstellt.

Mochida Pharmaceutical stock (JP3922800002) was trading at JPY 3,120 on the Tokyo Stock Exchange at 9:10 a.m. JST on October 7, 2026, down JPY 10, or 0.32 percent, from the previous close. The company enters the next reporting checkpoint after fiscal Q1 net income more than doubled from the preceding quarter.

Fiscal Q1 profit more than doubles

Investing.com reported fiscal Q1 revenue of JPY 31.719 billion for the quarter ended June 30, 2026, compared with JPY 29.464 billion in the preceding quarter. That is an increase of JPY 2.255 billion, or 7.65 percent.

The earnings improvement was sharper. Net income reached JPY 3.178 billion in fiscal Q1, up from JPY 1.561 billion in the preceding quarter, an increase of JPY 1.617 billion, or 103.59 percent. Diluted earnings per share stood at JPY 89.75 for the same period, giving the quarterly result a clear profit-led profile.

October 30 is the next checkpoint

TradingView lists October 30, 2026, as Mochida Pharmaceutical's next earnings date. The scheduled report will show whether the fiscal Q1 improvement continued into the following quarter, making revenue conversion and profit progression the main operating checkpoints.

The latest quarterly figures also provide a useful comparison for investors assessing the stock's valuation. Revenue grew by 7.65 percent sequentially, while net income increased by 103.59 percent, so the profit change was materially faster than the sales change.

Stock holds a JPY 3,000 level

The October 7 quote puts Mochida Pharmaceutical stock inside its JPY 2,929 to JPY 3,965 52-week range. The intraday range was JPY 3,100 to JPY 3,125, and volume stood at 4,600 shares at the quoted time.

Market capitalization was JPY 110.3 billion as of October 7, 2026. The modest 0.32 percent daily decline keeps the price action secondary to the upcoming earnings date and the durability of the recent profit increase.

Mochida Pharmaceutical stock key facts

  • Company: Mochida Pharmaceutical Co., Ltd.
  • ISIN: JP3922800002
  • Ticker: 4534
  • Trading venue: Tokyo Stock Exchange Prime
  • Price (as of October 7, 2026, 9:10 a.m. JST): JPY 3,120
  • Market capitalization: JPY 110.3 billion (as of October 7, 2026)
  • 52-week range: JPY 2,929-3,965 (as of October 7, 2026)
  • Sector / Industry: Health Care / Pharmaceuticals
  • Index membership: TOPIX Small 2

Upcoming dates for Mochida Pharmaceutical stock

  • October 30, 2026: Next earnings report

More news and analyses on Mochida Pharmaceutical stock

Disclaimer...

en | JP3922800002 | MOCHIDA | boerse | 70247646 | bgmi